Details

NameSymbolSector
NOVELIX PHARMACEUTICALS LIMITEDNOVELIXPharmacy Retail
Open
65.85
High
65.85
Low
62.2
Close
63.41
Volume
3858
Exchange
bse
Time
16-Oct-2026

Outlook

Score:  

0.75

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Novelix Pharmaceuticals is  
None
Estimated Stoploss of Novelix Pharmaceuticals is ₹  
65.85
Novelix Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Novelix Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Novelix Pharmaceuticals is in  
Downtrendℹ
. 
Price of Novelix Pharmaceuticals is  
Downℹ
 by  

11.4

%. 
Target
Buy @ 

63

Sell @ 

72

Current @ 

63.41

Volume

The trade volumes of Novelix Pharmaceuticals have become  
Deficientℹ
The volume trend for Novelix Pharmaceuticals is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Novelix Pharmaceuticals is  

Down

 by  

20.21

% 

Valuation

The current market price of Novelix Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 27cr and total assets worth ₹ 27cr, the balance sheet of Novelix Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Novelix Pharmaceuticals has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

50% i.e. ₹ 13cr spent in operatingℹ
7.69% i.e. ₹ 2cr earned in investingℹ
42.31% i.e. ₹ 11cr earned in financingℹ
0% in otherℹ
Income
The income of Novelix Pharmaceuticals is  

₹ 22cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Novelix Pharmaceuticals Losses increased by:  

0

% and Income is Up by:  

10

% 

(*Jun 2025)

The income of Novelix Pharmaceuticals is  

₹ 20cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Novelix Pharmaceuticals Losses increased by:  

0

% and Income is Up by:  

300

% 

(*Mar 2025)

The income of Novelix Pharmaceuticals is  

₹ 5cr

 and  

Loss

 is :  

₹ 0cr

(*Dec 2024)

Novelix Pharmaceuticals Losses increased by:  

0

% and Income is Up by:  

66.67

% 

(*Dec 2024)

Market Cap

Market capital of NOVELIX PHARMACEUTICALS LIMITED is 85cr

Top Rated Competitors

NameScore
Medplus Health Services Limited
0
By using this site you agree to the use of cookies to deliver a better site experience.